NMOSD’s are a category of autoimmune inflammatory illnesses that predominantly affect the optic nerves, spinal cord, brainstem, and infrequently the cerebrum. NMOSD is distinguished by recurring episodes of visual, motor, and/or sensory impairment, which frequently culminate in severe neurological abnormalities. Although there has been substantial progress in relapse treatment and prevention in recent years, the residual impairment per attack remains high. Despite the fact that symptomatic and restorative research in NMOSD has been restricted, several treatment techniques can be deduced from published case series and information from the multiple sclerosis literature. We will explore established and new therapeutic approaches for symptomatic therapy and function restoration in NMOSD in this review. We highlight NMOSD-specific concerns and prospective future research fields.
